IKBKB and lung carcinoma: This is nicely demonstrated by the reduced tumor burden detected in mouse models of K-Ras induced lung cancer carrying conditional ablation of Ikbkb or Rela, or transgenic expression of an IκBα-superrepressor; similar observations were made in melanoma among other cancers [3,4,5,6].